About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization.
| Publication Type | Review |
| Authors | Hamawy A, Lee L, Crystal R, Rosengart T |
| Journal | Curr Opin Cardiol |
| Volume | 14 |
| Issue | 6 |
| Pagination | 515-22 |
| Date Published | 11/01/1999 |
| ISSN | 0268-4705 |
| Keywords | Coronary Disease, Genetic Therapy, Myocardial Revascularization, Neovascularization, Pathologic |
| Abstract | Angiogenesis, the de novo formation of new vasculature, is a critical response to ischemia that provides neovascularization of ischemic tissues. In therapeutic angiogenesis, an angiogen--a mediator that induces angiogenesis--is delivered to targeted tissues, augmenting the native angiogenic process and enhancing reperfusion of ischemic tissues. Gene transfer is a novel means of providing therapeutic angiogenesis: the cDNA coding for specific angiogens, rather than the proteins themselves, is administered to the tissues in which angiogenesis is desired. This review is focused on therapeutic angiogenesis based on gene transfer strategies for the provision of myocardial revascularization. |
| DOI | 10.1097/00001573-199911000-00012 |
| PubMed ID | 10579070 |